XL Tan, A Le, H Tang, M Brown, E Scherrer, J Han… - Cancers, 2022 - mdpi.com
Simple Summary Brain metastases are common with severe consequences in patients with melanoma. We conducted a systematic literature review to evaluate the proportion of …
V Internò, MC Sergi, ME Metta, M Guida, P Trerotoli… - Cancers, 2023 - mdpi.com
Simple Summary The treatment strategies of patients with melanoma brain metastases are continually evolving, although this remains a poor prognostic subset. We report a real-life …
C Franklin, P Mohr, L Bluhm, F Meier… - … for ImmunoTherapy of …, 2023 - ncbi.nlm.nih.gov
Background Despite the availability of effective systemic therapies, a significant number of advanced melanoma patients develops brain metastases. This study investigated …
S Derks, K de Joode, E Mulder, LS Ho, A Joosse… - ESMO open, 2022 - Elsevier
Background The incidence of melanoma is increasing and 37% of patients with metastatic melanoma eventually have brain metastasis (BM). Currently, there is no consensus on …
AZ Wei, M Uriel, A Porcu, MP Manos… - Frontiers in …, 2022 - frontiersin.org
Metastatic uveal melanoma (mUM) is an advanced ocular malignancy characterized by a hepatotropic pattern of spread. As the incidence of brain metastases (BM) in mUM patients …
AC Eggen, TT Wind, I Bosma, MCA Kramer… - Cancer …, 2021 - Wiley Online Library
Background Novel treatments make long‐term survival possible for subsets of patients with melanoma brain metastases. Brain magnetic resonance imaging (MRI) may aid in early …
Background Recent data suggest that patients with stage III melanoma are at high risk for developing central nervous system (CNS) metastases. Because a subset of patients with …
CS Padilla, VKY Ho, T Mooijenkind… - Journal of Neuro …, 2023 - Springer
Background Although patients with melanoma of unknown primary (MUP) have a better prognosis than similar-staged melanoma patients with known primary, the occurrence of …
P Rutkowski, D Kiprian, T Świtaj… - Oncology in Clinical …, 2024 - journals.viamedica.pl
Melanoma is the third most frequent malignancy (after breast and lung cancers) that causes metastases in the central nervous system (CNS). It is one of the 20 most common human …